| ALKERMES PLC DL-,01 |
| Irland |
| Gesundheit |
| IE00B56GVS15 / A1JKVH |
| 8AK (Frankfurt) / ALKS (NASDAQ) |
| FRA:8AK, ETR:8AK, 8AK:GR, NASDAQ:ALKS |
| - |
| https://www.alkermes.com/ |
|
Alkermes plc is a prominent biopharmaceutical comp..
>Volltext.. |
| 4486.71 Mio. EUR |
| 3598.7 Mio. EUR |
| 1314.44 Mio. EUR |
| 335.84 Mio. EUR |
| 292.75 Mio. EUR |
| 1.79 EUR |
| 61.86 Mio. EUR |
| 532.61 Mio. EUR |
| 467.5 Mio. EUR |
| 2.34 |
| -4.09% |
| -3.56% |
| - |
| - |
| - |
| ALKERMES |
| 01.11.25 |
|